High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption

被引:1
|
作者
Drouin-Chartier, Jean-Philippe [1 ,2 ,3 ]
Tremblay, Andre J. [1 ]
Bergeron, Jean [2 ,3 ]
Lamarche, Benoit [4 ]
Couture, Patrick [1 ,2 ,3 ]
机构
[1] Laval Univ, Dept Med, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
[2] Laval Univ, CHU Quebec, Dept Med, Lipid Clin, Quebec City, PQ, Canada
[3] Laval Univ, CHU Quebec, Dept Med, Lipid Res Ctr, Quebec City, PQ, Canada
[4] Laval Univ, Sch Nutr, Inst Nutr & Funct Foods, Quebec City, PQ, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Homozygous familial hypercholesterolemia; Lipoprotein apheresis; Dextran sulfate adsorption; Triglyceride; LDL-Cholesterol; CORONARY-HEART-DISEASE; LDL RECEPTOR GENE; CARDIOVASCULAR-DISEASE; FRIEDEWALD FORMULA; CHOLESTEROL; PLASMA; MUTATION; HYPERLIPOPROTEINEMIA; APOLIPOPROTEIN(A); POPULATION;
D O I
10.1016/j.atherosclerosis.2018.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Maximizing the acute reduction of LDL-cholesterol (C) and lipoprotein (a) (Lp(a)) concentrations in patients with homozygous familial hypercholesterolemia (HoFH) is the main goal of lipoprotein apheresis (LA). The objective of this study was to examine how the pre-LA serum TG concentrations influence the efficacy of LA to acutely reduce LDL-C and Lp(a) concentrations in HoFH patients. Methods: Data from 1761 LA treatments of HoFH patients (n = 10) and compound heterozygous patients (n = 5) collected between 2008 and 2016 were analyzed. These data included the pre-and post-LA concentrations of LDL-C, TGs and Lp(a); volume of filtered plasma; type of LA system used (dextran sulfate adsorption (DSA) or heparin-induced extracorporeal LDL precipitation (HELP)); and interval between treatments. Results: A significant association between the pre-LA TG concentrations and acute LA-induced reduction in LDL-C, modified by the type of LA system used, was observed (p pre-LA TG quartile*LA system =.04). Using the DSA system, the acute reduction of the LDL-C concentrations was attenuated by 3.9% when the preLA TG concentrations were > 2.09 mmol/L vs. <= 0.93 mmol/L (highest vs. lowest quartiles: =59.4% vs. =63.3%, p =.007). Using the HELP system, no significant difference was observed in the reduction of LDL-C between the highest and the lowest quartiles of serum TGs (=65.8% vs. =66.4%, p =.9). No association was observed between pre-LA TG concentrations and acute LA-induced decrease in Lp(a) (p =.2). Conclusions: The efficacy of LA is inversely associated with pre-LA TG concentrations in HoFH patients who used the DSA system instead of the HELP system. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 50 条
  • [21] CHANGES IN LIPOPROTEIN(A), LDL-CHOLESTEROL AND APOLIPOPROTEIN-B IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH DEXTRAN SULFATE LDL-APHERESIS
    LASUNCION, MA
    TERUEL, JL
    ALVAREZ, JJ
    CARRERO, P
    ORTUNO, J
    GOMEZCORONADO, D
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (12) : 819 - 826
  • [22] Apheresis Treatment does not Affect the Lipid-Lowering Efficacy of Lomitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, in Patients with Homozygous Familial Hypercholesterolemia
    Cuchel, Marina
    Meagher, Emma A.
    Theron, H. du Toit
    Blom, Dirk
    Marais, A. D.
    Hegele, Robert A.
    Averna, Maurizio
    Sirtori, Cesare
    Shah, Prediman K.
    Gaudet, Daniel
    Stefanutti, Claudia
    Vigna, Giovanni B.
    du Plessis, A. M. E.
    Bloedon, LeAnne T.
    Rader, Daniel J.
    CIRCULATION, 2012, 126 (21)
  • [23] EXTRACORPOREAL LIPID ELIMINATION (LDL-APHERESIS) IN THE TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA - DIFFERENTIAL FILTRATION VERSUS DEXTRAN SULFATE ADSORPTION
    SCHWANER, I
    VONBAEYER, H
    GRAFENHAHN, H
    SCHWERDTFEGER, R
    SCHWARTZKOPFF, W
    BIOMEDIZINISCHE TECHNIK, 1988, 33 (06): : 130 - 136
  • [24] Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry
    Luirink, Ilse K.
    Hutten, Barbara A.
    Greber-Platzer, Susanne
    Kolovou, Genovefa D.
    Dann, Eldad J.
    de Ferranti, Sarah D.
    Taylan, Christina
    Bruckert, Eric
    Saheb, Samir
    Oh, Jun
    Driemeyer, Joenna
    Farnier, Michel
    Pape, Lars
    Schmitt, Claus P.
    Novoa, Francisco J.
    Maeser, Martin
    Masana, Luis
    Shahrani, Awad
    Wiegman, Albert
    Groothoff, Jaap W.
    ATHEROSCLEROSIS, 2020, 299 : 24 - 31
  • [25] Low-density lipoprotein apheresis with different intervals in patients with homozygous familial hypercholesterolemia: does time matter?
    Temizhan, A.
    Cetin, E. H. Ozcan
    Cetin, M. S.
    Tak, B. Tekin
    EUROPEAN HEART JOURNAL, 2018, 39 : 1109 - 1109
  • [26] 3 DIFFERENT SCHEDULES OF LOW-DENSITY-LIPOPROTEIN APHERESIS COMPARED WITH PLASMAPHERESIS IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    BERGER, GM
    FIRTH, JC
    JACOBS, P
    WOOD, L
    MARAIS, AD
    HORAK, A
    AMERICAN JOURNAL OF MEDICINE, 1990, 88 (02): : 94 - 100
  • [27] Real-world experience of long-term efficacy and safety of evinacumab in patients with homozygous familial hypercholesterolemia treated and untreated with lipoprotein apheresis
    Stefanutti, Claudia
    Chan, Dick C.
    Zeppa, Giovanna
    Watts, Gerald F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (05) : e817 - e824
  • [28] Effect of LDL-apheresis with dextran sulpfate cellulose adsorption (DS-LDL/A) on coronary atherosclerosis in homozygous familial hypercholesterolemia (FH)
    Edigio, P
    Avelar, E
    Veríssimo, E
    Gaspar, A
    Bruges, M
    Crespo, F
    Machado, P
    Gaddi, A
    Fellin, R
    Pais, J
    Gomes, S
    ATHEROSCLEROSIS, 1999, 144 : 43 - 43
  • [29] The LDL Receptor Genotype Among Patients With Homozygous Familial Hypercholesterolemia is a Significant Determinant of the Rebound Increase in LDL-C Concentrations Following Lipoprotein Apheresis
    Drouin-Chartier, Jean-Philippe
    Tremblay, Andre J.
    Bergeron, Jean
    Lamarche, Benoit
    Couture, Patrick
    CIRCULATION, 2016, 134
  • [30] Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis
    Galiano, Matthias
    Hammersen, Johanna
    Sauerstein, Katja
    Blessing, Holger
    Ruemmele, Petra
    Purbojo, Ariawan
    Schoeber, Martin
    Moosmann, Julia
    Raffelsbauer, Gunter
    Heibges, Andreas
    Klingel, Reinhard
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (03) : 163 - 171